Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avita Medical Inc (AVH.AX)

Avita Medical Inc (AVH.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avita Medical Inc 28159 Avenue Stanford Suite 220, Valencia Los Angeles CA 91355 USA

https://www.avitamedical.com P: 833-462-8482

Description:

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Key Statistics

Overview:

Market Capitalization, $K 341,695
Shares Outstanding, K 128,999
Annual Sales, $ 50,143 K
Annual Net Income, $ -35,381 K
Last Quarter Sales, $ 14,195 K
Last Quarter Net Income, $ -7,065 K
% of Institutional Shareholders 0.17%

Growth:

1-Year Return -43.50%
3-Year Return -49.25%
5-Year Return -72.45%
5-Year Revenue Growth 106.33%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.28
Dividend Payout Ratio 0.00%
Most Recent Split 5-100 on 06/24/20

AVH.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -52.89%
Return-on-Assets % -33.71%
Profit Margin % -70.56%
Debt/Equity 0.85
Price/Sales 4.49
Price/Book 4.67
Book Value/Share 0.58
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar